DCM Shriram Fine Chemicals promoter acquires 3.52% stake via gift

1 min read     Updated on 18 Aug 2026, 12:06 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Mrs. Urvashi Tilakdhar acquires 3.52% stake in DCM Shriram Fine Chemicals via inter-family gift from Mr. Akshay Dhar and Ms. Aditi Dhar. Her holding rises to 30.94%, while total promoter stake remains at 50.11%. The deal is exempt from open offer under SEBI Regulation 10(1)(a).

powered bylight_fuzz_icon
48580595

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals Limited disclosed on August 17, 2026, that Mrs. Urvashi Tilakdhar will acquire a 3.52% equity stake in the company through an inter-family gift. The shares are being transferred from Mr. Akshay Dhar and Ms. Aditi Dhar, both immediate relatives and promoters of the firm. The proposed acquisition date is August 24, 2026.

The transfer involves a total of 30,53,531 equity shares with a face value of ₹2 each. Mr. Akshay Dhar is transferring 15,26,766 shares (1.76%), while Ms. Aditi Dhar is transferring 15,26,765 shares (1.76%). The consideration for this acquisition is nil, as it is classified as a gift out of love and affection among immediate relatives.

Shareholding Changes

Following the transaction, Mrs. Urvashi Tilakdhar’s individual holding will increase from 27.42% to 30.94%. The total shareholding of the promoter group remains unchanged at 50.11%, as the shares are merely being consolidated within the family structure. The volume-weighted average market price of the shares for the 60 trading days preceding the notice was ₹24.92 per share.

Entity Pre-Acquisition Holding Shares Transferred Post-Acquisition Holding
Mrs. Urvashi Tilakdhar 27.42% (2,38,52,675 shares) Acquires 30,53,531 shares 30.94% (2,69,06,206 shares)
Mr. Akshay Dhar 1.76% (15,26,766 shares) Transfers all shares 0%
Ms. Aditi Dhar 1.76% (15,26,765 shares) Transfers all shares 0%
Promoter Group Total 50.11% Internal Transfer 50.11%

Regulatory Compliance

The acquisition is exempt from the requirement to make an open offer under Regulation 10(1)(a)(i) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This exemption applies because the transfer is between promoters or persons acting in concert who are immediate relatives.

Mrs. Urvashi Tilakdhar has declared that all conditions specified under Regulation 10(1)(a) have been duly complied with. Both the transferors and the transferee have confirmed their compliance with the applicable disclosure requirements under Chapter V of the Takeover Regulations. The declaration was digitally signed by Mrs. Urvashi Tilakdhar on August 17, 2026.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+2.00%+4.04%+6.69%-45.24%-45.24%-45.24%

How might the consolidation of promoter holdings under Mrs. Tilakdhar influence future corporate governance decisions or strategic direction at DCM Shriram?

Given the nil consideration and family nature of the transfer, are there potential tax implications or regulatory scrutiny risks for the involved parties in the coming fiscal year?

Could this internal restructuring signal a broader succession plan within the Dhar family that might affect investor confidence in management stability?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like16
dislike

DCM Shriram Fine Chemicals posts Q1FY27 profit of ₹2.4 crore; appoints Rudra Shriram as MD

2 min read     Updated on 15 Aug 2026, 03:22 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

DCM Shriram Fine Chemicals posted a standalone net profit of ₹2.42 crore in Q1FY27, reversing a ₹4.08 crore loss in the previous quarter. Consolidated profits reached ₹2.59 crore. Revenue declined 8% YoY to ₹9,160 lakh but improved sequentially. The board appointed Rudra Shriram as MD and Rakesh Malhotra as Independent Director.

powered bylight_fuzz_icon
48246553

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals Limited returned to profitability in the first quarter of FY27, reporting a standalone net profit of ₹2.42 crore for the period ended June 30, 2026. This marks a significant turnaround from the net loss of ₹4.08 crore recorded in the immediately preceding quarter (Q4FY26). On a consolidated basis, the company reported a net profit of ₹2.59 crore, compared to a consolidated loss of ₹3.83 crore in Q4FY26.

Revenue from operations showed a slight contraction year-on-year but stabilized sequentially. Standalone total income from operations for Q1FY27 was ₹9,159.96 lakh, down from ₹9,928.67 lakh in the same quarter last year (Q1FY26). However, this represented an improvement from the ₹9,351.29 lakh logged in Q4FY26. Consolidated total income from operations stood at ₹9,184.13 lakh.

Leadership Changes

In a significant governance development, the Board of Directors approved several key personnel changes during its meeting on August 14, 2026:

  • Resignation: Mr. Akshay Dhar resigned from his positions as Managing Director and CEO effective close of business hours on August 14, 2026. The company stated he is stepping away from day-to-day management to focus on leading new projects and expansion initiatives.
  • New Appointment: Mr. Rudra Shriram, son of Chairman Alok B Shriram, was inducted as an Additional Director and appointed Managing Director for a five-year term effective August 15, 2026. He currently serves as Deputy Managing Director at DCM Shriram International Limited.
  • Independent Director: Mr. Rakesh Malhotra was appointed as an Additional Director in the category of Non-Executive Independent Director for a five-year term, subject to member approval.

What the Numbers Show

The return to profitability was driven by a combination of reduced expenses and higher other income, despite a slight dip in core sales. Standalone other income rose to ₹81.86 lakh in Q1FY27 from ₹43.18 lakh in Q4FY26, contributing significantly to the bottom line given the thin operating margins.

Operating expenses remained relatively stable, with total expenses at ₹8,806.91 lakh in Q1FY27 compared to ₹9,833.47 lakh in Q4FY26. Notably, cost of materials consumed increased to ₹6,067.65 lakh from ₹5,693.39 lakh in the previous quarter, while employee benefits expense remained flat at ₹1,221.19 lakh. The reduction in overall expenses, coupled with the rise in other income, allowed the company to bridge the gap between revenue and costs, resulting in a pre-tax profit of ₹3.53 lakh versus a pre-tax loss of ₹4.82 lakh in Q4FY26.

Metric Q1FY27 (Standalone) Q4FY26 (Standalone) Q1FY26 (Standalone)
Total Income from Operations ₹9,159.96 lakh ₹9,351.29 lakh ₹9,928.67 lakh
Other Income ₹81.86 lakh ₹43.18 lakh ₹66.80 lakh
Total Expenses ₹8,806.91 lakh ₹9,833.47 lakh ₹9,374.39 lakh
Profit Before Tax ₹3.53 lakh -₹4.82 lakh ₹5.54 lakh
Net Profit ₹2.42 lakh -₹4.08 lakh ₹4.13 lakh

The financial results were reviewed by Kirtane & Pandit LLP, the statutory auditors, who issued an unmodified conclusion. The results have been prepared in accordance with Ind AS 34 and Regulation 33 of the SEBI LODR Regulations.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+2.00%+4.04%+6.69%-45.24%-45.24%-45.24%

How will the transition of leadership to Rudra Shriram impact DCM Shriram Fine Chemicals' strategic focus on new projects and expansion initiatives?

Given that profitability was driven largely by other income rather than core sales growth, what operational measures are being taken to improve thin operating margins in Q2FY27?

Will the appointment of Rakesh Malhotra as an Independent Director bring specific governance changes or expertise relevant to the fine chemicals sector?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like18
dislike

More News on DCM Shriram Fine Chemicals

1 Year Returns:-45.24%